Mycenax Biotech Inc.
Contract development and manufacturing organization (CDMO) focused on biologics and biosimilars. Provides integrated services from cell line and process development through PIC/S cGMP drug substance and drug product manufacturing, analytical characterization, and regulatory support. Operates GMP-compliant facilities and reports successful inspections by multiple global regulators.
Industries
Nr. of Employees
medium (51-250)
Mycenax Biotech Inc.
Products
PlasMX™ Plasmid DNA Manufacturing
A proprietary plasmid production platform providing cost-effective, high-quality plasmid DNA manufacturing services with flexible scaling and customizable quality grades for applications such as viral vector production, mRNA vaccines, and DNA vaccines.
Microbial Manufacturing
End-to-end microbial manufacturing and CDMO services covering cell line development, upstream process development, and downstream purification for recombinant proteins, plasmids, enzymes, cytokines, and antibody fragments.
ExoMX™ Exosome Manufacturing
A state-of-the-art, scalable, and GMP-compliant platform integrating a 3D microcarrier-based bioreactor process with TFF and chromatography-based purification for high-quality extracellular vesicle and exosome production.
Bispecific Antibody Production
CDMO services for bispecific antibody production, optimizing every stage of the BsAb lifecycle from design to high-yield GMP production.
Plas One-stop CDMO Solution
Mycenax's comprehensive plasmid DNA manufacturing platform delivering plasmid DNA in research, high-quality, and GMP grades with manufacturing capabilities from 5L to 200L scale.
Process Development
Comprehensive biomanufacturing process development services including production cell lines, upstream process development, downstream process development, process scale-up, formulation development, and analytical methods.
PlasMX™ Plasmid DNA Manufacturing
A proprietary plasmid production platform providing cost-effective, high-quality plasmid DNA manufacturing services with flexible scaling and customizable quality grades for applications such as viral vector production, mRNA vaccines, and DNA vaccines.
Microbial Manufacturing
End-to-end microbial manufacturing and CDMO services covering cell line development, upstream process development, and downstream purification for recombinant proteins, plasmids, enzymes, cytokines, and antibody fragments.
ExoMX™ Exosome Manufacturing
A state-of-the-art, scalable, and GMP-compliant platform integrating a 3D microcarrier-based bioreactor process with TFF and chromatography-based purification for high-quality extracellular vesicle and exosome production.
Bispecific Antibody Production
CDMO services for bispecific antibody production, optimizing every stage of the BsAb lifecycle from design to high-yield GMP production.
Plas One-stop CDMO Solution
Mycenax's comprehensive plasmid DNA manufacturing platform delivering plasmid DNA in research, high-quality, and GMP grades with manufacturing capabilities from 5L to 200L scale.
Process Development
Comprehensive biomanufacturing process development services including production cell lines, upstream process development, downstream process development, process scale-up, formulation development, and analytical methods.
Expertise Areas
- Bioprocess development (upstream and downstream)
- Cell line development and GMP cell banking
- Plasmid DNA production and QC
- Antibody‑drug conjugate development and linker chemistry
Key Technologies
- Transposon-based stable gene integration
- Single-cell high-throughput optofluidic screening
- Miniature high-throughput bioreactors (scale-down models)
- Fed-batch and continuous perfusion cell culture